SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001558370-23-019202
Filing Date
2023-11-17
Accepted
2023-11-17 16:51:18
Documents
59
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A gpcr-20230630x10qa.htm   iXBRL 10-Q/A 2774629
2 EX-31.1 gpcr-20230630xex31d1.htm EX-31.1 15758
3 EX-31.2 gpcr-20230630xex31d2.htm EX-31.2 16042
4 EX-32.1 gpcr-20230630xex32d1.htm EX-32.1 9952
5 EX-32.2 gpcr-20230630xex32d2.htm EX-32.2 10239
6 GRAPHIC gpcr-20230630x10qa001.jpg GRAPHIC 31575
  Complete submission text file 0001558370-23-019202.txt   8605764

Data Files

Seq Description Document Type Size
7 EX-101.SCH gpcr-20230630.xsd EX-101.SCH 42964
8 EX-101.CAL gpcr-20230630_cal.xml EX-101.CAL 43539
9 EX-101.DEF gpcr-20230630_def.xml EX-101.DEF 182565
10 EX-101.LAB gpcr-20230630_lab.xml EX-101.LAB 416071
11 EX-101.PRE gpcr-20230630_pre.xml EX-101.PRE 312228
53 EXTRACTED XBRL INSTANCE DOCUMENT gpcr-20230630x10qa_htm.xml XML 1456434
Mailing Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080 (628) 229-9277
Structure Therapeutics Inc. (Filer) CIK: 0001888886 (see all company filings)

IRS No.: 981480821 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-41608 | Film No.: 231419542
SIC: 2834 Pharmaceutical Preparations